🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesGLP-1 and peripheral arterial disease — claudication improvement data

GLP-1 and peripheral arterial disease — claudication improvement data

Dr.CardioMD Wed, May 27, 2026 at 12:54 AM 8 replies 449 viewsPage 1 of 2
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
May 27, 2026 at 12:54 AM#1

Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

The question I want answered is how much of the SELECT benefit is plausibly independent of the weight loss, and whether that distinction changes anything practical.

I have searched first, so if this is covered somewhere point me at it and I will read it.

3 23kim_atl_prep, sarah_TO, wendy_avl
Reply Quote Save Share Report
KevinCompounds
VIP Member
5,432
18,234
Dec 2023
Nevada
May 27, 2026 at 1:38 AM#2
Dr.CardioMD said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

I'm 55 years old and want to share my perspective on cardiovascular risk as an older member of this community.

My doctor was initially hesitant because of my age, but the SELECT trial included patients up to 72 and showed consistent benefit across age groups. We started at the lowest dose with closer monitoring.

13 months later: down 40 lbs, off atorvastatin, A1C from 8.0% to 5.5%. My cardiologist is thrilled. cardiovascular risk is absolutely relevant for older adults — don't let anyone tell you otherwise.

2 22Dr.RaviCardio, jennifer_SEA
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
May 27, 2026 at 2:22 AM#3
KevinCompounds said:
I'm 55 years old and want to share my perspective on cardiovascular risk as an older member of this community.

Positive "side effect" of cardiovascular risk: my blood pressure dropped so much that I'm now off losartan entirely! My cardiologist is thrilled.

If you're on BP meds and losing weight on a GLP-1, monitor your BP at home regularly. Hypotension symptoms (dizziness, lightheadedness when standing) mean your BP meds may need reduction. Don't wait for your next scheduled appointment — call your doctor.

1 21FranDenver
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
SaraMom3
Member
456
2,345
Aug 2024
Ohio
May 27, 2026 at 3:06 AM#4
Dr.CardioMD said:
Prescribed on cardiovascular grounds rather than for weight, and almost everything written for patients assumes the opposite.

Adding a me-too, because a thread of one person's experience is not much use. I had assumed I was the exception until I read this.

Last edited: May 27, 2026 at 7:06 AM
50 20CanadaChris, ZaraB_AL, JakeSmashed95 and 47 others
Reply Quote Save Share Report
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
May 27, 2026 at 7:13 AM#5

Adding the clinical framing, because it changes how the question reads.

6 month update on cardiovascular risk: down 64 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

49 19SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 46 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register